¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Receptors, Lysophosphatidic Acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® acetylsalicylic acid ÇÑ±Û ¾Æ¼¼Æ¿»ì¸®½Ç»ê
¼³¸í   
  »óǰ¸íÀÌ ¾Æ½ºÇǸ°(asprin)ÀΠ¾à. ´ëÇ¥ÀûÀΠºñ½ºÅ×·ÎÀ̵å Ç׿°¾àÀÌ´Ù. Áï Ç׿°Áõ(anti-inflammatory), ÁøÅë(analgesis), ÇØ¿­(anti-pyretic)ÀÇ È¿°ú°¡ ¸ðµÎ ¶Ù¾î³ªÁö¸¸ À§ÀåÀå¾Ö, °ú´ÙÈ£Èí, ¶óÀÌÁõÈıº(Reye syndrome) µîÀÇ ºÎÀÛ¿ëÀÌ ÀÖ´Ù.
¿µ¹® uric acid ÇÑ±Û ¿ä»ê
¼³¸í   
  °áÁ¤¼ºÀÇ »ê. 2, 6, 8-trioxypurine. È­ÇнÄÀº C5H4N4O3·Î »ç¶÷°ú µ¿¹°ÀÇ ¿ÀÁÜ¿¡¼­ ¾òÀ» ¼ö ÀÖ´Ù. ÇÙÀÇ ´ë»ç»ê¹°ÀÇ Çϳª. ¹°, ¾ËÄÝ, ¿¡Å׸£(ether)¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª ¾ËÄ®¸®¿°ÀÇ ¿ë¾×¿¡´Â ³ì´Â´Ù. À̰ÍÀÇ ³ªÆ®·ý¿° ÇüÅÂ(sodium urate)°¡ °á¼®ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÑ´Ù. ±Þ¼º¹éÇ÷º´ Ä¡·á Ãʱâ´Ü°è¿Í Åëdz(Gout)¿¡¼­ Ç÷Áß¿ä»êÀÌ ±Þ°ÝÈ÷ ¿À¸¦ ¼ö ÀÖ´Ù. 
¿µ¹® acid-fast bacillus ÇÑ±Û Ç׻긷´ë±Õ, Ç×»ê±Õ
¼³¸í   
  ¾Æ´Ò¸° »ö¼Ò¿¡ ¿°»öµÇ±â Èûµå³ª ÀÏ´Ü ¿°»öµÇ¸é °­»êÀ¸·Î Ã³¸®ÇÏ¿©µµ Å»»öµÇÁö ¾Æ´ÏÇϴ ¼¼±ÕÀ» ÅëÆ²¾î À̸£´Â ¸». °áÇØ±Õ, ³ªº´±Õ µûÀ§°¡ ÀÖ´Ù.
¿µ¹® acid-fast staining ÇÑ±Û Ç׻꿰»ö
¼³¸í   
  Ç׻꼺¼ºÁú(Á»Ã³·³ ¿°»öÀÌ µÇÁö ¾ÊÀ¸³ª Çѹø ¿°»öÀÌ µÇ¸é »ê¼º¿ë¾×¿¡ ÀÇÇØ¼­ Å»»öÀÌ µÇÁö ¾Ê´Â ¼ºÁú)À» °¡Áø ±Õ(¿¹¸¦ µé¸é °áÇÙ±Õ µî)ÀÇ °ËÃâ¿¡ ÀÌ¿ëµÇ´Â ¿°»ö¹æ¹ý. ¹æ¹ý¿¡´Â Ziehl-Neelson¹ý°ú Kinyoun¹ý µîÀÌ ÀÖ´Ù.
¿µ¹® nucleic acid ÇÑ±Û ÇÙ»ê
¼³¸í   
  ¿°±â, ´ç, ÀλêÀ¸·Î ÀÌ·ç¾îÁø ´ºÅ¬·¹¿ÀƼµå°¡ ±ä »ç½½ ¸ð¾çÀ¸·Î ÁßÇյȠ°íºÐÀÚ ¹°Áú. À¯ÀüÀ̳ª ´Ü¹éÁú ÇÕ¼ºÀ» Áö¹èÇϴ Áß¿äÇÑ ¹°Áú·Î, »ý¹°ÀÇ Áõ½ÄÀ» ºñ·ÔÇÑ »ý¸í È°µ¿ À¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù. ±¸¼º ´çÀΠ¿Àź´çÀÌ ¸®º¸¿À½ºÀΠ¸®º¸ÇÙ»ê°ú µð¿Á½Ã¸®º¸¿À½ºÀΠµð¿Á½Ã¸®º¸ ÇÙ»êÀ¸·Î ³ª´¶´Ù. ÆæÅ佺·Î¼­ ¸®º¸½º³ª µ¥¿Á½Ã¸®º¸½º ¾î´À ÇÑÂʸ¸À» Æ÷ÇÔÇϸç ÀüÀÚ¸¦ ¸®º¸ÇÙ»ê(RNA), ÈÄÀÚ¸¦ µ¥¿Á½Ã¸®º¸ÇÙ»ê(deoxyribonucleic acid, DNA)À̶ó ºÎ¸¥´Ù. ¸ðµÎ 4Á¾·ùÀÇ À¯±â¿°±â¿¡ ÀÇÇØ Æ¯Â¡Áö¾îÁö¸ç ¾Æµ¥´Ñ, ±¸¾Æ´Ñ ¹× ½ÃÅä½ÅÀº ¾çÀÚ¿¡ °øÅëÀÌ´Ù. Æ¼¹ÎÀº DNA¿¡, ¿ì¶ó½ÇÀº RNA¿¡ Æ÷ÇԵȴÙ. DNA´Â ÁַΠÇÙ¿¡ Á¸ÀçÇϸç ÇüÁúÀ¯Àü¿¡ ±×¸®°í RNA´Â ¼¼Æ÷Áú¼Ó¿¡¼­ ´Ü¹éÁú ÇÕ¼º¿¡ °ü¿©ÇÑ´Ù. ¼·ÃëµÈ ÇÙ»êÀº ¼ÒÈ­°ü¿¡¼­ ±¸¼ººÐÀڷαîÁö °¡¼öºÐÇØµÇ¾î Èí¼öµÈ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å°Ë»ç
  • acid lipase
    »ê¼ºÁöÁúºÐÇØÈ¿¼Ò
  • acid maltase
    »ê¼º¸»Å¸¾ÆÁ¦
  • acid mucopolysaccharide
    »ê¼ºÁ¡¾×´Ù´ç·ù, »ê¼º¹ÂÄÚ´Ù´ç·ù
  • acid phosphatase
    »ê¼ºÀλêºÐÇØÈ¿¼Ò
  • acid pyuria
    »ê¼º°í¸§´¢, »ê¼º³ó´¢
  • acid radical
    »ê±â, »ê¶óµðÄ®
  • acid rain
    »ê¼ººñ
  • acid salt
    »ê¿°
  • acid therapy
    »ê¿ä¹ý
  • acid-base compensation
    »ê¿°±âº¸»ó
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • acid-base indicator
    »ê¿°±âÁö½Ã°è
  • acid-fast
    Ç×»ê-
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hydrochloric acid
    ¿°»ê
  • mandelic acid
    ¸¸µ¨¸°»ê
  • methylhippuric acid
    ¸ÞÆ¿¸¶´¢»ê
  • nucleic acid
    ÇÙ»ê
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyruvic acid
    ÇÇ·çºê»ê
  • retinoic acid
    ·¹Æ¼³ë»ê, ·¹Æ¼³ëÀλê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • succinic acid
    ¼÷½Å»ê
  • sulfuric acid
    Ȳ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acid fast organism
    Ç×»ê±Õ
  • acid lipase deficiency
    »ê¼ºÁöÁúºÐÇØÈ¿¼Ò°áÇÌ
  • acid-base compensation
    »ê¿°±âº¸»ó
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • acid-base indicator
    »ê¿°±âÇ¥Áö½Ã°è
  • acid-fast bacillus
    Ç׻긷´ë±Õ, Ç×»ê±Õ
  • acid-fast bacterium
    Ç×»ê±Õ
  • acid-fast stain
    Ç׻꿰»ö
  • aliphatic amino acid
    Áö¹æ¾Æ¹Ì³ë»ê
  • allokainic acid
    ¾Ë·ÎÄ«Àλê
  • amino acid
    ¾Æ¹Ì³ë»ê
  • amino acid sequence
    ¾Æ¹Ì³ë»ê¼ø¼­
  • aminohippuric acid
    ¾Æ¹Ì³ë¸¶´¢»ê
  • anthranilic acid
    ¾ÈÆ®¶ó´Ò»ê
  • arachidonic acid
    ¾Æ¶ó۵·»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Left ventricular receptors
    Á½ɽǼö¿ëü(ñ§ãýãøáôé»ô÷)
  • M1 muscarinic receptors
    M1 ¹«½ºÄ«¸°¼º ¼ö¿ëü(áôé»ô÷)
  • presynaptic receptors
    ½Å°æÁ¢ÇÕÀü ¼ö¿ëü
  • 3,4-dihydroxyphenylacetic acid, homogentisic acid
    3,4-µðÈ÷µå·Ï½ÃÆä´Ò ¾Æ¼¼Æ¾»ê= È£¸ð°Õƾ»ê
  • abietinic acid ; abietic acid
    ¾Æºñ¿¡Æ¾»ê.
  • acetic anhydride-acetic acid-sulfuric acid
    ¹«¼öÃÊ»ê-ÃÊ»ê-Ȳ»ê
  • acid-base balance=acid-base equilibrium
    »ê¿°±â ÆòÇü(¡­øÁû¬)
  • hydroxyindoleacetic acid, 5-hydroxyindoleacetic acid (5-hiaa)
    5-ÇÏÀ̵å·Ï½ÃÀε¹¾Æ¼¼Æ®»ê
  • 3,5-dinitrobenzoic acid
    3,5-µð´ÏÆ®·Îº¥Á¶»ê
  • 3-hydroxybutyric acid
    3-È÷µå·Ï½Ã³«»ê
  • 5-hydroxyindoleacetic acid
    5-È÷µå·Ï½ÃÀε¹¾Æ¼¼Æ®»ê, 5-È÷µå·Ï½ÃÀε¹ÃÊ»ê
  • Chenodeoxycholic acid
    Äɳëµð¿Á½ÃÄÝ»ê
  • Cholic acid
    ´ãÁó»ê¿°
  • Deoxycholic acid
    µð¿Á½ÃÄݸ¯»ê
  • Deoxyribonucleic acid
    µð¿Á½Ã¸®º¸´ºÅ¬·¹ÀÍ»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê.
  • acetylsalicylic acid
    ¾Æ¼¼Æ¿»ì¸®½Ç»ê
  • acid phosphatase
    »êÀλêÈ¿¼Ò
  • acid alcohol
    »ê¼º¾ËÄÚ¿Ã.
  • acid ash diet
    »ê¼º½ÄÀÌ.
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acid bath
    »ê¿å(ß«é±).
  • acid burn
    »ê¼ºÈ­»ó
  • acid burn
    »ê¼º¿Ü»ó, »ê¼ºÈ­»ó.
  • acid catalyser
    »êÃ˸Å(ß«õºØÚ).
  • acid challenge test
    »ê Åõ¿©½ÃÇè
  • acid citrate dextrose
    »ê ±¸¿¬»ê¿°Æ÷µµ´ç
  • acid dyspepsia
    ´Ù»ê¼º(Òýß«àõ) ¼ÒÈ­ºÒ·®(Áõ).
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å½ÃÇè
  • acid error
    »ê¿ÀÂ÷(ß«è¦ó¬).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acid-citrate-dextrose solution
    »ê(ß«)-½ÃÆ®¸£»ê-(ß«)µ¦½ºÆ®·Î½º ¿ë¾×(éÁäû)
  • acid-fast
    Ç׻꼺 (ù÷ß«àõ)
  • acid-thiol ligase
    »ê(ß«)ŸÀ̿öóÀ̰ÔÀ̽º
  • acidic amino acid
    »ê¼º(ß«àõ)¾Æ¹Ì³ë»ê(ß«)
  • active amino acid
    Ȱ¼º(üÀàõ)¾Æ¹Ì³ë»ê (ß«)
  • adenylic acid
    ¾Æµ¥´Ò»ê(ß«)
  • aldaric acid
    ¾Ë´Ù¸£»ê(ß«)
  • aldonic acid
    ¾Ëµ·»ê(ß«)
  • alginic acid
    ¾Ë±ä»ê(ß«)
  • alpha amino acid
    ¾ËÆÄ¾Æ¹Ì³ë»ê(ß«)
  • amino acetic acid
    ¾Æ¹Ì³ë¾Æ¼¼Æ®»ê(ß«)
  • amino acid
    ¾Æ¹Ì³ë»ê(ß«)
  • amino acid accepting RNA
    ¾Æ¹Ì³ë»ê(ß«) ¼ö³³(áôÒ¡)RNA
  • amino acid activating enzyme
    ¾Æ¹Ì³ë»ê(ß«) Ȱ¼ºÈ­(üÀàõûù) È¿¼Ò(ý£áÈ)
  • amino acid activation
    ¾Æ¹Ì³ë»ê(ß«) Ȱ¼ºÈ­(üÀàõûù)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OA obstructive apnea; occipital artery; occipito-anterior; occiput anterior; octanoic acid; ocular albi...
PAA partial agonist activity; phenylacetic acid; phosphonoacetic acid; physical abilities analysis; plas...
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
DHA dehydroacetic acid; dehydroascorbic acid; dehydroepiandrosterone; dihydroacetic acid; dihydroxyaceto...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CR1 C3b-C4b receptors
CB1 cannabinoid 1 receptors
EGFr Epithelial Growth Factor receptors
ER, PR Estrogen and progesterone receptors
FcR Fc gamma Receptors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acid fast bacilli
    Ç׻꼺 °£±Õ
    ÀϹÝÀûÀ¸·Î °£»ó ¼¼±Õ ¶Ç´Â Eubacteriales¸ñÀÇ Æ÷ÀÚ Çü¼º °£±ÕÀ» °¡¸®Å²´Ù.
  • acid fast bacteria
    Ç×»ê ¼¼±Õ, Ç׻꼺 ¼¼±Õ
    Ç׻꼺À» °¡Áö´Â ±Õ. °áÇÙ±ÕÀÌ ´ëÇ¥ÀûÀÓ.
  • acid fast staining
    Ç×»ê ¿°»ö
  • acid food
    »ê¼º ½Äǰ
    ¿¬¼ÒÇßÀ» °æ¿ì¿¡ ȸºÐ¿¡ À½À̿ ¼ººÐÀÌ ¸¹±â ¶§¹®¿¡ »ê¼ºÀ» º¸ÀÌ´Â ½ÄǰÀÌ´Ù. °î·ù, À°·ù µîÀº Cl, S, P µîÀÇ ¿ø¼Ò¸¦ ¸¹ÀÌ ÇÔÀ¯Çϱ⠶§¹®¿¡ ü³»¿¡¼­ ¿¬¼Ò ºÐÇØµÇ¸é »ê¼ºÀ¸·Î ±â¿î´Ù. ½Äǰ 100gÀ» ¿¬¼Ò½ÃÄѼ­ »ý¼ºµÈ ȸºÐÀ» ÁßÈ­Çϴµ¥ ÇÊ¿äÇÑ 1±ÔÁ¤ÀÇ ¾ËÄ®¸® ¿ë·®À¸·Î ±× Á¤µµ¸¦ Ç¥½ÃÇÑ´Ù.
  • acid gel
    Á©Çü »ê
  • acid intoxication
    »ê Áßµ¶, »ê Áßµ¶Áõ
  • acid mucopolysaccharide
    »ê¼º Á¡¾× ´Ù´ç·ù
  • acid phosphatase assay
    »ê¼º Æ÷½ºÆÄŸÁ¦ ÃøÁ¤
  • acid radical
    »ê±â
    À¯±â, ¹«±âÀÇ °¢Á¾ »êÀÇ ºÐÀڷκÎÅÍ ¼ö¼Ò ÀÌ¿ÂÀ¸·Î¼­ ÀÌ¿ÂÈ­ ÇÒ ¼ö ÀÖ´Â ¼ö¼Ò ¿øÀÚ¸¦ ÇÑ °³ ÀÌ»ó ¶¼¾î ³½ ³ª¸ÓÁö ¿øÀÚ ¶Ç´Â ¿øÀÚ´Ü.
  • acid spring
    »ê¼º õ
    ¹° 1kg ¼Ó¿¡ ¼ö¼ÒÀ̿ 1mg ÀÌ»óÀ» ÇÔÀ¯Çϸç À½À̿°ú Á¶ÇÕ½ÃŰ¸é ¿°»êÀ̳ª Ȳ»ê°ú °°Àº À¯¸® ±¤»êÀ» ±¸¼ºÇÑ´Ù. ÀϺ» µî È­»êÀÌ ¸¹Àº ³ª¶óÀÇ Æ¯À¯ÇÑ ¿ÂõÀ̸ç, ºÐÈ­±¸, ºÐ±â°ø ±Ùó¿¡¼­ ¼Ú¾Æ ³ª¿À´Â ÀÏÀÌ ¸¹°í, ÀϹÝÀûÀ¸·Î °í¿ÂÀÌ´Ù. Ȳȭ¼ö¼Ò, ¸í¹Ý, ³ì¹Ý µîÀ» µ¿½Ã¿¡ ÇÔÀ¯Çϰí ÀÖ´Ù. ÇǺÎÀÇ ÀÚ±ØÀÌ °­Çϰí Áþ¹«¸§ÀÌ ÀϾ±â ½¬¿ì¹Ç·Î ÇǺο°¿¡ ÁÖÀÇÇÑ´Ù.
  • acid tide
    »êÁõ°¡±â
    ÀϽÃÀûÀ¸·Î ¿äÀÇ »êµµ°¡ Áõ°¡ÇÏ´Â Çö»ó.
  • acid value
    »ê°ª, »ê°¡
    À¯Áö 1g¿¡ ÇÔÀ¯µÈ À¯¸® Áö¹æ»êÀ» ÁßÈ­Çϴµ¥ ÇÊ¿äÇÑ ¼ö»êÈ­Ä®·ýÀÇ §·¼ö¸¦ »ê°¡¶ó ÇÑ´Ù. À¯Áö´Â ¿À·¡ µÇ¸é À¯¸® Áö¹æ»êÀÌ Áõ°¡ÇϹǷΠ½Å¼±µµ µîÀÇ ±âÁØÀÌ µÈ´Ù. ½Ä¿ëÀ¯Áö´Â »ê°¡ 1 ÀÌÇÏÀÇ °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù°í ÇÑ´Ù.
  • acid-base
    »ê ¿°±â
  • acid-base balance disturbance
    »ê ¿°±â ÆòÇü ÀÌ»ó
    »ê°ú ¿°±âÀÇ ÆòÇüÀÌ ±úÁø »óÅÂ.
  • acid-base compensation
    »ê ¿°±â º¸»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
receptors, adrenergic Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction.
(12 Dec 1998)
receptors, adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors. The alpha-beta distinction was originally based on cellular effects of receptor activation but now relies on the relative affinities for certain synthetic ligands. Alpha-adrenergic receptors are further subdivided into several subclasses based on studies of endogenous and cloned receptors.
(12 Dec 1998)
receptors, adrenergic, alpha-1 A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-1 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist phenylephrine and the antagonist prazosin. They are widespread, with clinically important concentrations in the liver, the heart, vascular, intestinal, and genitourinary smooth muscle, and the central and peripheral nervous systems.
(12 Dec 1998)
receptors, adrenergic, alpha-2 A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-2 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist clonidine and the antagonist yohimbine. They are found on pancreatic beta cells, platelets, and vascular smooth muscle, as well as both pre- and postsynaptically in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, adrenergic, beta One of the two major pharmacologically defined classes of adrenergic receptors. The alpha-beta distinction was originally based on the cellular effects of receptor activation but now relies on the relative affinities for characteristic synthetic ligands. Beta adrenergic receptors are further subdivided based on information from endogenous and cloned receptors.
(12 Dec 1998)
receptors, adrenergic, beta-1 A subclass of beta-adrenergic receptors (receptors, adrenergic, beta). Beta-1 adrenergic receptors are equally sensitive to epinephrine and norepinephrine and bind the agonist dobutamine and the antagonist metoprolol with high affinity. They are found in the heart, juxtaglomerular cells, and in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, adrenergic, beta-2 A subclass of beta-adrenergic receptors (receptors, adrenergic, beta). Beta-2 adrenergic receptors are more sensitive to epinephrine than to norepinephrine and have a high affinity for the agonist terbutaline. They are widespread, with clinically important roles in skeletal muscle, liver, and vascular, bronchial, gastrointestinal, and genitourinary smooth muscle.
(12 Dec 1998)
receptors, albumin Cell surface proteins that bind albumin with high affinity and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, aldosterone Cytoplasmic proteins that specifically bind aldosterone and mediate its cellular effects. The aldosterone-bound receptor acts in the nucleus to regulate the transcription of specific segments of DNA.
(12 Dec 1998)
receptors, ampa Cell surface proteins that bind glutamate and directly gate ion channels in cell membranes. Ampa receptors were originally discriminated from other glutamate receptors by their affinity for the agonist ampa (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid). They are probably the most common mediators of fast excitatory synaptic transmission in the central nervous system. Several subtypes have been cloned, and for some types the traditional distinction from kainate receptors may not apply.
(12 Dec 1998)
receptors, androgen Proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. The complex of the androgen and receptor migrates to the nucleus where it induces transcription of specific segments of DNA.
(12 Dec 1998)
receptors, angiotensin Cell surface proteins that bind angiotensins and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, antigen Molecules on the surface of b- and T-lymphocytes that recognise and combine with specific antigens.
(12 Dec 1998)
receptors, antigen, B-cell Immunoglobulin molecules on the surface of B-lymphocytes that recognise and bind antigen.
(12 Dec 1998)
receptors, antigen, T-cell Molecules on the surface of T-lymphocytes that recognise and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (antigens, CD3). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (receptors, antigen, T-cell, alpha-beta) or gamma-delta (receptors, antigen, T-cell, gamma-delta) chains.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • carbolic acid
    ¼®Åº»ê
  • carbonic acid
    ź»ê
  • carbonic acid gas
    ź»ê°¡½º
  • cevitamic acid
    ºñŸ¹Î C
  • chloric acid
    ¿°¼Ò»ê
  • chlorous acid
    ¾Æ¿°¼Ò»ê
  • cyanic acid
    ½Ã¾È»ê
  • deoxyribonucleic acid
    µð¿Á½Ã¸®º¸ ÇÙ»ê
  • dichlorophenlxyacetic acid
    (È­)µðŬ·Î·ÎÆä³ì½Ã¾Æ¼¼Æ®»ê(±× ³ªÆ®·ý¿°Àº Á¦ÃÊÁ¦)
  • essential amino acid
    (È­)Çʼö ¾Æ¹Ì³ë»ê
  • ethacrynic acid
    (¾à)¿¡Å¸Å©¸°»ê
  • fatty acid
    Áö¹æ»ê
  • folic acid
    ¿±»ê(ºóÇ÷ÀÇ Æ¯È¿Á¦)
  • formic acid
    Æ÷¸§»ê
  • fulminic acid
    ³ú»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á